3 Results for "

drowsiness

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "drowsiness" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13988
CAS No.: 162640-98-4
Purity:  99.75%
Target:  

PGE synthase

Research Areas:  

Inflammation/Immunology

AT-56 is a potent, selective and orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS), with an IC50 of 95 μM and Ki of 75 μM. AT-56 could selectively suppress the drowsiness or pain reaction mediated by L-PGDS-catalyzed PGD2 .
loading...
    loading...
Cat. No.: HY-P99436
CAS No.: 1370261-50-9
Synonyms: ABR-214936
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
loading...
    loading...
Cat. No.: HY-13988R
CAS No.: 162640-98-4
Research Areas:  

Inflammation/Immunology

AT-56 (Standard) is the analytical standard of AT-56. This product is intended for research and analytical applications. AT-56 is a potent, selective and orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS), with an IC50 of 95 μM and Ki of 75 μM. AT-56 could selectively suppress the drowsiness or pain reaction mediated by L-PGDS-catalyzed PGD2 .
loading...
    loading...